caelumbio.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:
Meta Tags
Title Caelum Biosciences – A Biotechnology
Description A Clinical Stage Biotechnology About Us Management Team Board of Directors CAEL-101 AL Amyloidosis Expanded Access Policy Publications Clinical Trials Trial Locations News Contact Us Ab
Keywords N/A
Server Information
WebSite caelumbio faviconcaelumbio.com
Host IP 155.130.138.21
Location United States
Related Websites
Site Rank
More to Explore
caelumbio.com Valuation
US$5,873,470
Last updated: 2023-05-02 21:40:08

caelumbio.com has Semrush global rank of 1,802,053. caelumbio.com has an estimated worth of US$ 5,873,470, based on its estimated Ads revenue. caelumbio.com receives approximately 677,708 unique visitors each day. Its web server is located in United States, with IP address 155.130.138.21. According to SiteAdvisor, caelumbio.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$5,873,470
Daily Ads Revenue US$5,422
Monthly Ads Revenue US$162,650
Yearly Ads Revenue US$1,951,800
Daily Unique Visitors 45,181
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
caelumbio.com. A 3600 IP: 155.130.138.21
caelumbio.com. NS 7200 NS Record: ns92.worldnic.com.
caelumbio.com. NS 7200 NS Record: ns91.worldnic.com.
caelumbio.com. MX 3600 MX Record: 10 caelumbio-com.mail.protection.outlook.com.
caelumbio.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-02 21:40:08
About Us Management Team Board of Directors CAEL-101 AL Amyloidosis Expanded Access Policy Publications Clinical Trials Trial Locations News Contact Us About Us Management Team Board of Directors CAEL-101 AL Amyloidosis Expanded Access Policy Publications Clinical Trials Trial Locations News Contact Us A Clinical Stage Biotechnology Company Caelum Biosciences is developing treatments for AL Amyloidosis, a rare and life-threatening hematologic disorder. LEARN MORE Have you recently been diagnosed with AL Amyloidosis? FIND A TRIAL NEAR YOU Caelum Biosciences has two ongoing Phase 3 clinical trials to determine if CAEL-101 has a benefit in patients with severe Cardiac AL Light Chain Amyloidosis Location Rutgers Ecocomplex 1200 Florence Columbus Rd, Bordentown, NJ 08505 Email Us Navigate Home About Us CAEL-101 Clinical Trials Trial Locations Contact Us Recent News Fortress Biotech Announces Closing of Acquisition of Caelum Biosciences by AstraZeneca October 6, 2021 Fortress Biotech
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Mon, 25 Oct 2021 05:56:20 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Powered-By: PHP/7.4.24
X-Pingback: http://caelumbio.com/xmlrpc.php
X-Redirect-By: WordPress
Location: https://caelumbio.com/
Vary: User-Agent
Referrer-Policy: no-referrer-when-downgrade
X-Powered-By: PleskLin

HTTP/2 200 
server: nginx
date: Mon, 25 Oct 2021 05:56:22 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
x-powered-by: PHP/7.4.24
x-pingback: https://caelumbio.com/xmlrpc.php
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
vary: User-Agent
referrer-policy: no-referrer-when-downgrade
x-powered-by: PleskLin
caelumbio.com Whois Information
Domain Name: CAELUMBIO.COM
Registry Domain ID: 2073508890_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2020-09-13T06:59:15Z
Creation Date: 2016-11-12T15:20:46Z
Registry Expiry Date: 2021-11-12T15:20:46Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS91.WORLDNIC.COM
Name Server: NS92.WORLDNIC.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-13T10:17:35Z <<<

Copyright © 2022 WebZZ.US 0.0213